# Arterial Spin Labeling Blood Flow Magnetic Resonance Imaging for the Evaluation of Response to Therapy in Metastatic Renal Cell Carcinoma

> **NCT00953446** · NA · TERMINATED · sponsor: **Beth Israel Deaconess Medical Center** · enrollment: 2 (actual)

## Conditions studied

- Renal Cell Carcinoma

## Interventions

- **PROCEDURE:** Arterial Spin Labeling Blood Flow Magnetic Resonance Imaging

## Key facts

- **NCT ID:** NCT00953446
- **Lead sponsor:** Beth Israel Deaconess Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-06-15
- **Primary completion:** 2011-09-13
- **Final completion:** 2011-09-13
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2020-06-30

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00953446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00953446, "Arterial Spin Labeling Blood Flow Magnetic Resonance Imaging for the Evaluation of Response to Therapy in Metastatic Renal Cell Carcinoma". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT00953446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*